Today: 13 May 2026
Lululemon founder Chip Wilson launches proxy fight for board shakeup as CEO exit nears
29 December 2025
2 mins read

Lululemon founder Chip Wilson launches proxy fight for board shakeup as CEO exit nears

NEW YORK, December 29, 2025, 12:27 ET

  • Chip Wilson nominated three independent director candidates in a proxy contest targeting Lululemon’s board.
  • The push comes weeks after CEO Calvin McDonald said he will depart in January, leaving interim co-CEOs in place.
  • Lululemon shares are down about 45% this year as rivals gain ground and activist pressure builds.

Lululemon Athletica founder Dennis “Chip” Wilson said on Monday he has launched a proxy fight to reshape the company’s board, nominating three independent director candidates. The Wall Street Journal first reported the move, which was also covered by Canadian outlets including CTV News https://www.ctvnews.ca/business/article/lu…, CBC https://www.cbc.ca/news/business/lululemon… and The Globe and Mail https://www.theglobeandmail.com/business/a….

The board challenge lands as the athleisure maker enters a leadership transition, with CEO Calvin McDonald set to leave in January and no named successor. Investors have been watching closely after Lululemon’s shares fell about 45% this year.

Lululemon has struggled to regain momentum with younger, higher-income shoppers and has faced rising competition from newer rivals such as Alo Yoga and Vuori. The pressure has also drawn activist interest, including from Elliott Management.

A proxy fight is a campaign to win board seats through a shareholder vote, often by putting forward an alternative slate of directors. Wilson is pushing for board changes before the company settles on its next permanent chief executive.

Wilson’s nominees include Marc Maurer, a former co-CEO of On Running, Laura Gentile, a former chief marketing officer at ESPN, and Eric Hirshberg, a former chief executive at Activision.

Lululemon’s board has installed Chief Financial Officer Meghan Frank and Chief Commercial Officer André Maestrini as interim co-CEOs while it searches for a permanent replacement.

Wilson said the board had failed to plan for succession and that shareholders have lost confidence in its ability to select and support the next CEO without directors who bring stronger product experience.

Elliott Management disclosed a roughly $1 billion stake in Lululemon earlier this month and has been pressing for changes as the company weighs its next leader. A person familiar with Wilson’s thinking said he is not coordinating with other investors and has indicated he would not back a CEO selection made before board changes.

Lululemon did not immediately respond to a request for comment. The company’s shares were up about 1% in morning trading on Monday.

“Adding three new board members seems like something that Lululemon would be willing to do,” Morningstar analyst David Swartz said.

Swartz also said Wilson may have avoided seeking a board seat himself because he holds a significant stake in Amer Sports, which competes in parts of the athletic and outdoor gear market.

Wilson is one of Lululemon’s largest independent shareholders, holding about 4.27% as of December, according to LSEG data.

Wilson founded Lululemon in 1998 and later stepped back from day-to-day operations before leaving the board in 2015 after disputes over strategy. An earlier board confrontation was defused when he sold a large portion of his stake to private-equity firm Advent International in exchange for additional board representation.

Stock Market Today

  • Analog Devices (ADI) Stock Valuation Assessment Amid Strong Price Gains
    May 13, 2026, 2:53 PM EDT. Analog Devices (ADI) stock has surged nearly 20% in the past 30 days and delivered an 87.95% total shareholder return over one year, drawing investor attention. The stock trades at $419.65, about 6.8% above its modeled fair value of $392.94, indicating potential overvaluation. Drivers include growth from robotics and automation expanding ADI's addressable market and boosting revenue. However, risks remain from increased competition in China and rising manufacturing and R&D costs that could pressure margins. Investors should weigh ADI's growth potential against these challenges when considering inclusion in portfolios.

Latest articles

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

13 May 2026
Palantir shares fell 4.4% to $129.97 Wednesday as CEO Alex Karp met President Volodymyr Zelenskiy in Kyiv to discuss expanding AI use in Ukraine’s war effort. Kyiv’s Brave1 Dataroom project, launched with Palantir, is training AI models to intercept Russian drones. Russia fired at least 800 drones at Ukraine on Wednesday, killing six. Palantir’s U.S. government and commercial revenue surged in the first quarter.
Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

13 May 2026
Grab shares fell 1.1% to $3.60 in New York after first-quarter revenue beat estimates, rising 24% to $955 million. Profit jumped to $120 million from $10 million a year earlier. Investors weighed strong results against Indonesia’s new 8% ride-hailing commission cap. Grab kept its 2026 revenue and adjusted EBITDA outlook unchanged.
SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

13 May 2026
SoFi acquired PrimaryBid’s technology to expand IPO access for retail investors, confirmed by both companies. SoFi shares fell 2.9% to $15.44 after Truist cut its price target, citing concerns over loan and technology platforms. The acquisition follows a drop in technology-platform accounts and comes as SoFi reported strong first-quarter revenue and member growth. Terms of the deal were not disclosed.

Popular

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
PepsiCo stock edges higher as Wall Street cools into year-end
Previous Story

PepsiCo stock edges higher as Wall Street cools into year-end

XRP treads water near $1.85 as crypto fund outflows persist ahead of Fed minutes
Next Story

XRP treads water near $1.85 as crypto fund outflows persist ahead of Fed minutes

Go toTop